Mechanistic models of infectious disease and their impact on public health

American Journal of Epidemiology

Volumn 183, Issue 5, 2016, Pages 415-422

  Lessler, Justin ^a   Cummings, Derek A T ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b University of Florida   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

infectious disease; mathematical modeling; public health policy

Indexed keywords

ANTIVIRUS AGENT; CHOLERA VACCINE;

DISEASE PREVALENCE; EPIDEMIC; EPIDEMIOLOGY; HEALTH IMPACT; HEALTH POLICY; INFECTIOUS DISEASE; NUMERICAL MODEL; PUBLIC HEALTH;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANOPHELES; CHIKUNGUNYA; CONCEPTUAL FRAMEWORK; CONGENITAL RUBELLA SYNDROME; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; FOOT AND MOUTH DISEASE; GOVERNMENT; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION CONTROL; MALARIA; MATHEMATICAL MODEL; PANDEMIC INFLUENZA; PAPILLOMAVIRUS INFECTION; PREDICTION AND FORECASTING; PREVALENCE; PUBLIC HEALTH; REVIEW; RUBELLA; SIMULATION; STUDY DESIGN; SYSTEM ANALYSIS; VACCINATION; COMMUNICABLE DISEASES; HISTORY; MARYLAND; SCHOOL; STATISTICS AND NUMERICAL DATA; THEORETICAL MODEL; UNIVERSITY;

COMMUNICABLE DISEASES; EPIDEMICS; EPIDEMIOLOGIC METHODS; EPIDEMIOLOGY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MARYLAND; MODELS, THEORETICAL; SCHOOLS, PUBLIC HEALTH; UNIVERSITIES;

EID: 84960402056     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kww021     Document Type: Review

References (88)

1. Sartwell PE. Memoir on the Reed-Frost epidemic theory. Am J Epidemiol. 1976; 103(2): 138-140
2. Fine PEM. A commentary on the mechanical analogue to the Reed-Frost epidemic model. Am J Epidemiol. 1977; 106(2): 87-100
3. Abbey H. An examination of the Reed-Frost theory of epidemics. Hum Biol. 1952; 24(3): 201-233
4. De Maia JO. Some mathematical developments on the epidemic theory formulated by Reed and Frost. Hum Biol. 1952; 24(3): 167-200
5. Sartwell PE. The distribution of incubation periods of infectious disease. Am J Hyg. 1950; 51(3): 310-318
6. Ferguson NM, Cummings DA, Cauchemez S,. et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature. 2005; 437(7056): 209-214
7. Eubank S, Guclu H, Kumar VSA,. et al. Modelling disease outbreaks in realistic urban social networks. Nature. 2004; 429(6988): 180-184
8. Balcan D, Gonçalves B, Hu H,. et al. Modeling the spatial spread of infectious diseases: the Global Epidemic and Mobility computational model. J Comput Sci. 2010; 1(3): 132-145
9. Ross R. Prevention of Malaria in Mauritius. London, United Kingdom: Waterlow and Sonds Limited; 1908
10. Ross R. Some quantitative studies in epidemiology. Nature. 1911; 87(2188): 466-467
11. Ross R. The principle of repeated medication for curing infections. Br Med J. 1921; 2(3157): 1-4
12. Smith DL, McKenzie FE, Snow RW,. et al. Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol. 2007; 5(3): e42
13. Macdonald G. Epidemiological basis of malaria control. Bull World Health Organ. 1956; 15(3-5): 613-626
14. Smith DL, Battle KE, Hay SI,. et al. Ross, Macdonald, and a theory for the dynamics and control of mosquito-transmitted pathogens. PLoS Pathog. 2012; 8(4): e1002588
15. Reiner RC Jr, Perkins TA, Barker CM,. et al. A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970-2010. J R Soc Interface. 2013; 10(81): 20120921
16. Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev. 1993; 15(2): 265-302
17. Heesterbeek JA. A brief history of R0 and a recipe for its calculation. Acta Biotheor. 2002; 50(3): 189-204
18. McLean AR, Anderson RM. Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiol Infect. 1988; 100(3): 419-442
19. Metcalf CJE, Lessler J, Klepac P,. et al. Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination. Epidemiol Infect. 2012; 140(12): 2290-2301
20. Riley S, Wu JT, Leung GM. Optimizing the dose of prepandemic influenza vaccines to reduce the infection attack rate. PLoS Med. 2007; 4(6): e218
21. Agur Z, Cojocaru L, Mazor G,. et al. Pulse mass measles vaccination across age cohorts. Proc Natl Acad Sci U S A. 1993; 90(24): 11698-11702
22. Azman AS, Lessler J. Reactive vaccination in the presence of disease hotspots. Proc Biol Sci. 2015; 282(1798): 20141341
23. Fenner F, Henderson DA, Arita I,. et al. Smallpox and Its Eradication. Geneva, Switzerland: World Health Organization; 1988. http: //apps.who.int/iris/bitstream/10665/39485/1/9241561106.pdf. Accessed February 10, 2016
24. Halloran ME, Longini IM Jr, Nizam A,. et al. Containing bioterrorist smallpox. Science. 2002; 298(5597): 1428-1432
25. Longini IM Jr, Halloran ME, Nizam A,. et al. Containing a large bioterrorist smallpox attack: a computer simulation approach. Int J Infect Dis. 2007; 11(2): 98-108
26. Kaplan EH, Wein LM. Smallpox bioterror response. Science. 2003; 300(5625): 1503-1504
27. Riley S, Ferguson NM. Smallpox transmission and control: spatial dynamics in Great Britain. Proc Natl Acad Sci U S A. 2006; 103(33): 12637-12642
28. Cooper LZ. The history and medical consequences of rubella. Rev Infect Dis. 1985; 7(suppl 1): S2-S10
29. Anderson RM, May RM. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond). 1983; 90(2): 259-325
30. Morice A, Ulloa-Gutierrez R, Avila-Agüero ML. Congenital rubella syndrome: progress and future challenges. Expert Rev Vaccines. 2009; 8(3): 323-331
31. Panagiotopoulos T, Berger A, Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review: How does herd immunity work?. BMJ. 1999; 319(7223): 1462-1467
32. World Health Organization. Rubella vaccines: WHO position paper-recommendations. Vaccine. 2011; 29(48): 8767-8768
33. Woolhouse ME, Dye C, Etard JF,. et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A. 1997; 94(1): 338-342
34. Lloyd-Smith JO, Schreiber SJ, Kopp PE,. et al. Superspreading and the effect of individual variation on disease emergence. Nature. 2005; 438(7066): 355-359
35. Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science. 1991; 253(5015): 37-42
36. Longini IM Jr, Clark WS, Gardner LI,. et al. The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach. J Acquir Immune Defic Syndr. 1991; 4(11): 1141-1147
37. Simons E, Ferrari M, Fricks J,. et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet. 2012; 379(9832): 2173-2178
38. Chen S, Fricks J, Ferrari MJ. Tracking measles infection through non-linear state space models. J R Stat Soc Ser C Appl Stat. 2012; 61(1): 117-134
39. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med. 2002; 76(1): 105-115
40. Beigel JH, Farrar J, Han AM,. et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005; 353(13): 1374-1385
41. Longini IM Jr, Nizam A, Xu S,. et al. Containing pandemic influenza at the source. Science. 2005; 309(5737): 1083-1087
42. Ferguson NM, Cummings DAT, Fraser C,. et al. Strategies for mitigating an influenza pandemic. Nature. 2006; 442(7101): 448-452
43. Germann TC, Kadau K, Longini IM Jr,. et al. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S A. 2006; 103(15): 5935-5940
44. Halloran ME, Ferguson NM, Eubank S,. et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A. 2008; 105(12): 4639-4644
45. Van Noorden R. Report disputes benefit of stockpiling tamiflu. Nature News. http: //www.nature.com/news/report-disputesbenefit-of-stockpiling-tamiflu-1.15022. Published April 10, 2014. Updated 2014. Accessed January 18, 2015
46. Jefferson T, Jones M, Doshi P,. et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-Analysis. BMJ. 2009; 339: b5106
47. Russell CA, Fonville JM, Brown AEX,. et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science. 2012; 336(6088): 1541-1547
48. Herfst S, Schrauwen EJ, Linster M,. et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science. 2012; 336(6088): 1534-1541
49. Imai M, Watanabe T, Hatta M,. et al. Experimental adaptation of an influenza H5 haemagglutinin (HA) confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 2012; 486(7403): 420-428
50. Lipsitch M, Galvani AP. Ethical alternatives to experiments with novel potential pandemic pathogens. PLoS Med. 2014; 11(5): e1001646
51. Fraser C, Donnelly CA, Cauchemez S,. et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009; 324(5934): 1557-1561
52. Lessler J, Reich NG, Cummings DAT,. et al. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med. 2009; 361(27): 2628-2636
53. Keeling MJ, Woolhouse ME, Shaw DJ,. et al. Dynamics of the 2001 UK foot and mouth epidemic: stochastic dispersal in a heterogeneous landscape. Science. 2001; 294(5543): 813-817
54. Lipsitch M, Cohen T, Cooper B,. et al. Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003; 300(5627): 1966-1970
55. Cauchemez S, Fraser C, Van Kerkhove MD,. et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014; 14(1): 50-56
56. WHO Ebola Response Team. Ebola virus disease in West Africa-The first 9 months of the epidemic and forward projections. N Engl J Med. 2014; 371(16): 1481-1495
57. Gomes MFC, Pastore Y, Piontti A,. et al. Assessing the international spreading risk associated with the 2014 West African Ebola outbreak. PLoS Curr. 2014; 6
58. Meltzer MI, Atkins CY, Santibanez S,. et al. Estimating the future number of cases in the Ebola epidemic-Liberia and Sierra Leone, 2014-2015. MMWR Surveill Summ. 2014; 63(suppl 3): 1-14
59. World Health Organization. Ebola Response Roadmap Situation Report 5 November 2014. Geneva, Switzerland: World Health Organization; 2014. http: //apps.who.int/iris/ bitstream/10665/137510/1/roadmapsitrep-5Nov14-eng.pdf. Accessed February 10, 2016
60. Fraser C, Riley S, Anderson RM,. et al. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci U S A. 2004; 101(16): 6146-6151
61. Ginsberg J, Mohebbi MH, Patel RS,. et al. Detecting influenza epidemics using search engine query data. Nature. 2009; 457(7232): 1012-1014
62. Ghani AC, Donnelly CA, Cox DR,. et al. Methods for estimating the case fatality ratio for a novel, emerging infectious disease. Am J Epidemiol. 2005; 162(5): 479-486
63. Pitzer VE, Viboud C, Simonsen L,. et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science. 2009; 325(5938): 290-294
64. Pitzer VE, Patel MM, Lopman BA,. et al. Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions. Proc Natl Acad Sci U S A. 2011; 108(48): 19353-19358
65. Halloran ME, Longini IM Jr, Struchiner CJ. Design and Analysis of Vaccine Studies. New York, NY: Springer; 2010
66. Kerry SM, Bland JM. Statistics notes: The intracluster correlation coefficient in cluster randomisation. BMJ. 1998; 316(7142): 1455-1460
67. Van De Velde N, Brisson M, Boily M-C. Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty. Am J Epidemiol. 2007; 165(7): 762-775
68. Yang Y, Longini IM Jr, Halloran ME. Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups. J R Stat Soc Ser C Appl Stat. 2006; 55(3): 317-330
69. Cori A, Ayles H, Beyers N,. et al. HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PLoS One. 2014; 9(1): e84511
70. Howley PM, Knipe DM, Fields BN. Fields Virology. Philadelphia, PA: Lippincott Williams & Wilkins; 2007
71. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A. 2014; 111(2): 787-792
72. Nunes JK, Woods C, Carter T,. et al. Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward. Vaccine. 2014; 32(43): 5531-5539
73. von Gottberg A, De Gouveia L, Tempia S,. et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014; 371(20): 1889-1899
74. Watson CH, Edmunds WJ. A review of typhoid fever transmission dynamic models and economic evaluations of vaccination. Vaccine. 2015; 33(suppl 3): C42-C54
75. Newall AT, Beutels P, Wood JG,. et al. Cost-effectiveness analyses of human papillomavirus vaccination. Lancet Infect Dis. 2007; 7(4): 289-296
76. Wein LM, Craft DL, Kaplan EH. Emergency response to an anthrax attack. Proc Natl Acad Sci U S A. 2003; 100(7): 4346-4351
77. Wu JT, Lee CK, Cowling BJ,. et al. Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic. Proc Natl Acad Sci U S A. 2010; 107(7): 3269-3274
78. Pybus OG, Rambaut A. Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet. 2009; 10(8): 540-550
79. NIH Fogarty International Center. Research and Policy for Infectious Disease Dynamics (RAPIDD). http: //www.fic.nih. gov/about/staff/pages/epidemiology-population.aspx#rapidd. Published January 17, 2013. Updated December 1, 2015. Accessed January 12, 2015
80. NIH National Institute for General Medical Sciences. Models of Infectious Disease Agent Study (MIDAS). https: //www.nigms. nih.gov/Research/specificareas/MIDAS/Pages/default.aspx. Published January 10, 2010. Updated May 1, 2015. Accessed August 12, 2015
81. School of Public Health, Imperial College London. About the Centre for Outbreak Analysis and Modelling. https: //www1. imperial.ac.uk/publichealth/departments/ide/outbreaks/background/. Created February 1, 2013. Accessed August 12, 2015
82. National Oceanic and Atmospheric Administration. Dengue Forecasting Project. http: //dengueforecasting.noaa.gov/docs/project-description.pdf. Created August 1, 2015. Accessed August 12, 2015
83. Servick K. Chikungunya threat inspires new DARPA challenge. Science. 2014. http: //news.sciencemag.org/health/ 2014/08/chikungunya-threat-inspires-new-darpa-challenge. Published August 15, 2014. Accessed January 12, 2015
84. Centers for Disease Control and Prevention. CDC Announces Winner of the "Predict the Influenza Season Challenge". 2014. http: //www.cdc.gov/flu/news/predict-flu-challenge-winner. htm. Accessed August 12, 2015
85. Granich RM, Gilks CF, Dye C,. et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009; 373(9657): 48-57
86. Azman AS, Luquero FJ, Ciglenecki I,. et al. The impact of a one-dose versus two-dose oral cholera vaccine regimen in outbreak settings: a modeling study. PLoS Med. 2015; 12(8): e1001867
87. Earn DJ, Rohani P, Bolker BM,. et al. A simple model for complex dynamical transitions in epidemics. Science. 2000; 287(5453): 667-670
88. En ko PD. On the course of epidemics of some infectious diseases. Int J Epidemiol. 1989; 18(4): 749-755